Croda International Plc, the company that uses smart science to create high-performance ingredients and solutions catering to the life sciences market, opens a new facility, Pastillator 4 (PS04) at its Seraya site, Jurong Island, Singapore.

PS04 represents a significant milestone that enables Croda to meet the growing global demand for pastille-format Alkoxylates and Ester, with easier and safer for customer handling, across Consumer Care, Life Sciences and Industrial Specialties markets.

Aligned with Croda’s strategic priority to deliver fast growth in Asia, this 22million (SGD) investment will bolster and expand the production capacity by an additional 4,600 MT of pastille products, advancing the site’s total capacity to 15,000 MT. It reduces lead-time for customers and supports Croda’s growth, innovation and sustainability targets.

Babu Alagappan, Croda Managing Director, commented: “Since inception, Croda Singapore has consistently invested in the Seraya site to ensure safe operations. Manufacturing quality, sustainable ingredients based on our customers’ needs is our competitive advantage. Our current investment to expand the pastillation capacity allows us to fulfil growing demand for pastilles. This adds to Croda’s innovative range of speciality chemicals that also supports our sustainability targets."

The British High Commissioner to Singapore, Kara Owen CMG and Croda Group Chief Executive, Steve Foots, were among the attendees.